Please login to the form below

Not currently logged in
Email:
Password:

Xeomin receives FDA approval

The FDA has approved Merz Pharmaceuticals' botulinum toxin type A for the treatment of adults with cervical dystonia and blepharospasm

The US Food and Drug Administration (FDA) has approved Merz Pharmaceutical's Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm.

Approval was based on the results of two pivotal US clinical trials involving adult patients diagnosed with either cervical dystonia or blepharospasm. Active comparator studies conducted in Europe, which evaluated Xeomin versus Botox (onabotulinumtoxinA), were also included in the data submitted in support of the registration filing in these conditions.

Jack Britts, president and CEO of Merz Pharmaceuticals commented that this is an important regulatory milestone for Xeomin and is key to establishing the company's neurology business in the US.

"We at Merz understand, and are committed to, addressing the complexities of treating and living with these neurological disorders," Britts said.

Xeomin is the only botulinum toxin that does not require refrigeration prior to reconstitution. Merz believes this attribute will simplify product distribution and storage, and help ensure product integrity at the time of injection.

The drug will be available in 50-unit and 100-unit vials, allowing dosing flexibility for administration.

2nd August 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....